[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-351538-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-351538-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","evaluation-of-a-national-breast-cancer-screening-program-in-a-middle-income-country-the-case-of-kazakhstan","Evaluation of a National Breast Cancer Screening Program in a Middle-Income Country - The Case of Kazakhstan","","Breast cancer is the most common cancer in Kazakhstan, where a population-based screening program began in 2008 for women aged 50–60 and expanded in 2018 to ages 40–70. The evaluation examines program outputs, outcomes, and associated expenditures using administrative datasets and official sources, summarizing trends with average annual percent change. Women screened increased steadily, yet coverage of eligible women declined, and screening detected about half of Stage I cases while contributing less than 30% to Stage II cancers. No statistically significant immediate or trend changes were observed in national incidence or mortality, informing evidence-based policy refinements.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/evaluation-of-a-national-breast-cancer-screening-program-in-a-middle-income-country-the-case-of-kazakhstan/351538/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/evaluation-of-a-national-breast-cancer-screening-program-in-a-middle-income-country-the-case-of-kazakhstan/351538.png","ImageObject",300,407,{"name":42,"@type":43},"นรินทร์","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-12","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",12,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"When was the national breast cancer screening program introduced and how did the target age group change?","Question",{"text":63,"@type":64},"The program was introduced in 2008 targeting women aged 50–60. It expanded in 2018 to include women aged 40–70.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What trends did the study observe regarding screening coverage and screened women?",{"text":68,"@type":64},"The absolute number of women screened increased steadily, but the proportion of eligible women covered declined over time, especially after the 2018 expansion.",{"name":70,"@type":61,"acceptedAnswer":71},"Did screening lead to measurable changes in breast cancer incidence or mortality in Kazakhstan?",{"text":72,"@type":64},"Neither the introduction nor the subsequent expansion was associated with statistically significant immediate or trend changes in national breast cancer incidence or mortality rates.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},351538,1790165332,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":109,"preview_page_count":33,"preview_urls":146},2336475104957,"https://ap-avatar.wpscdn.com/avatar/22000c4c6bd8a5076e1?x-image-process=image/resize,m_fixed,w_180,h_180&k=1787554080175789136","Article  \nEvaluation of a National Breast Cancer Screening Program in a Middle-Income Country: The Case of Kazakhstan  \nYuliya Semenova 1, Zhandos Burkitbayev 2,*, Sanzhar Shalekenov 2, Oxana Shatkovskaya 2,  \nGauhar Dunenova 3, Alma Zhylkaidarova 4, Azat Chinaliyev 2, Baurzhan Anapiya 5, Asel Sadvakassova 6, Ayan Yerekesh 5, Zhadyra Karashutova 7, Almira Manatova 8, * and Lyudmila Pivina 9  \nAcademic Editor: Nicola Magnavita  \nReceived: 3 March 2026  \nRevised: 13 April 2026  \nAccepted: 17 April 2026  \nPublished: 19 April 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Department of Surgery, School of Medicine, Nazarbayev University, Astana 010000, Kazakhstan; [yuliya.semenova@nu.edu.kz](yuliya.semenova@nu.edu.kz)  \n2 Management Board, National Research Oncology Center, Astana 010000, Kazakhstan; [s.shalekenov@gmail.com](s.shalekenov@gmail.com) (S.S.); [1972arty@mail.ru](1972arty@mail.ru) (O.S.); [medicinaastana@gmail.com](medicinaastana@gmail.com) (A.C.)  \n3 Khoja Akhmet Yassawi International Kazakh-Turkish University, Turkestan 161200, Kazakhstan; [gauhar.dunenova@gmail.com](gauhar.dunenova@gmail.com)  \n4 Specialized Consultative and Diagnostic Department, Almaty Regional Multispecialty Medical Center, Almaty 050060, Kazakhstan; [almazhylkaidarova@gmail.com](almazhylkaidarova@gmail.com)  \n5 Vascular and Reconstructive Surgery Center, National Research Oncology Center, Astana 010000, Kazakhstan; [plastic.nroc@gmail.com](plastic.nroc@gmail.com) (B.A.); [ayerekesh@gmail.com](ayerekesh@gmail.com) (A.Y.)  \n6 Women’s Health Center, National Research Oncology Center, Astana 010000, Kazakhstan; [asadvakassova@outlook.com](asadvakassova@outlook.com)  \n7 Department of Medical and Statistical Analysis, Salidat Kairbekova National Research Center for Health Development, Astana Z00T6E0, Kazakhstan; [zh.karashutova@nrchd.kz](zh.karashutova@nrchd.kz)  \n8 Department of Scientific Management, National Research Oncology Center, Astana 020000, Kazakhstan  \n9 Department of Emergency Medicine, Semey Medical University, Semey 071400, Kazakhstan; [lyudmila.pivina@smu.edu.kz](lyudmila.pivina@smu.edu.kz)  \n* Correspondence: [zhan11@mail.ru](zhan11@mail.ru) (Z.B.); [almira.baltakaeva@gmail.com](almira.baltakaeva@gmail.com) (A.M.)  \nHighlights  \nPublic health relevance—How does this work relate to a public health issue?  \n• The study evaluates a national breast cancer screening program that affects millions of eligible women and represents a major public health investment.  \n• It addresses the gap between screening implementation and its population-level impact on breast cancer incidence and mortality in Kazakhstan.  \nPublic health significance—Why is this work of significance to public health?  \n• Findings show that despite expanding coverage, the program has not produced observable changes in national breast cancer incidence or mortality trends.  \n• The results highlight critical discrepancies between program outputs, early detection performance and international benchmarks for effective screening.  \nPublic health implications—What are the key implications or messages for practitioners, policy makers and/or researchers in public health?  \n• Suboptimal coverage levels and limited contribution of screening to early-stage breast cancer diagnoses suggest the need to refine program targeting and implementation.  \n• Policymakers may consider revising age eligibility, increasing participation and enhancing performance monitoring to ensure more efficient and impactful use of public health resources.  \nAbstract  \nBreast cancer (BC) is the most common cancer in Kazakhstan, and a population-based breast cancer screening program was introduced in 2008, initially targeting women aged  \nInt. J. Environ. Res. Public Health 2026, 23, 532 [https://doi.org/10.3390/ijerph23040532](https://doi.org/10.3390","cbCaiq8GvBZpg6Gb","https://ap.wps.com/l/cbCaiq8GvBZpg6Gb","pdf",623096,16,"English","# Highlights\n## Public health relevance\n## Public health significance\n## Public health implications\n# Abstract\n# Keywords\n# Introduction","[{\"question\":\"When was the national breast cancer screening program introduced and how did the target age group change?\",\"answer\":\"The program was introduced in 2008 targeting women aged 50–60. It expanded in 2018 to include women aged 40–70.\"},{\"question\":\"What trends did the study observe regarding screening coverage and screened women?\",\"answer\":\"The absolute number of women screened increased steadily, but the proportion of eligible women covered declined over time, especially after the 2018 expansion.\"},{\"question\":\"Did screening lead to measurable changes in breast cancer incidence or mortality in Kazakhstan?\",\"answer\":\"Neither the introduction nor the subsequent expansion was associated with statistically significant immediate or trend changes in national breast cancer incidence or mortality rates.\"}]","Evaluation of a National Breast Cancer Screening Program in a Middle-Income Country - The Case of Kazakhstan | PDF",1790094634,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c2f61d9a98a1e8387142981329c56d3e.webp",983,1390,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/729122cde5a6dcc74c847b8967ed813d.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e74b83d1f9459f0be9850517e6921e94.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/945d516596f6eb9d81bc9f0769968013.webp",980,1385]